{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Supplementary Table 2"],"read":"whole","date_system":"1900"}

{"sheet":"Supplementary Table 2","index":0,"n_rows":6,"n_cols":8,"rows_kept":6,"merged":[[3,0,4,0],[3,1,4,1],[3,2,4,2],[3,3,4,3],[3,4,4,4],[3,5,4,5],[3,6,4,6],[3,7,4,7]]}
["Supplementary Table 2. Background of NPC cell lines"]
["NPC cell lines","Tumour characteristics ","Treatment ","HLA type","MAGED4B","FJX1","EBV copy number","HLA expression"]
["NPC-268","Primary","None","A2/ A11","++","+++","+ (6 copies)","+"]
["NPC-43","Recurrent","Chemoradiotherapy then adjuvant chemotherapy","A11","+++","+","+++ (10 copies)","++"]
[]
["NPC-53","Recurrent ","Chemoradiotherapy alone","A11/A24","+","+++","Negative","+++"]